Melodiol inks deal to sell Mernova facility to wipe out debts by Steve Jones July 23, 2024July 23, 2024 Melodiol Global Health has agreed to sell its Mernova facility in Canada for up to A$14.2 […]
Melodiol ponders options amid ‘challenging and volatile capital markets’ by Steve Jones June 19, 2024June 19, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma by Martin Lane and Steve Jones April 16, 2024July 16, 2024
Health House to open its own telehealth clinic this quarter by Martin Lane April 9, 2024July 16, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023